1. Home
  2. APLS vs IPAR Comparison

APLS vs IPAR Comparison

Compare APLS & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • IPAR
  • Stock Information
  • Founded
  • APLS 2009
  • IPAR 1982
  • Country
  • APLS United States
  • IPAR United States
  • Employees
  • APLS N/A
  • IPAR N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • IPAR Package Goods/Cosmetics
  • Sector
  • APLS Health Care
  • IPAR Consumer Discretionary
  • Exchange
  • APLS Nasdaq
  • IPAR Nasdaq
  • Market Cap
  • APLS 3.6B
  • IPAR 4.1B
  • IPO Year
  • APLS 2017
  • IPAR 1988
  • Fundamental
  • Price
  • APLS $27.52
  • IPAR $134.27
  • Analyst Decision
  • APLS Buy
  • IPAR Strong Buy
  • Analyst Count
  • APLS 18
  • IPAR 5
  • Target Price
  • APLS $46.71
  • IPAR $159.40
  • AVG Volume (30 Days)
  • APLS 1.4M
  • IPAR 112.2K
  • Earning Date
  • APLS 02-28-2025
  • IPAR 02-25-2025
  • Dividend Yield
  • APLS N/A
  • IPAR 2.22%
  • EPS Growth
  • APLS N/A
  • IPAR N/A
  • EPS
  • APLS N/A
  • IPAR 4.67
  • Revenue
  • APLS $715,216,000.00
  • IPAR $1,419,560,000.00
  • Revenue This Year
  • APLS $97.25
  • IPAR $12.47
  • Revenue Next Year
  • APLS $12.68
  • IPAR $3.44
  • P/E Ratio
  • APLS N/A
  • IPAR $28.88
  • Revenue Growth
  • APLS 162.10
  • IPAR 9.22
  • 52 Week Low
  • APLS $24.34
  • IPAR $108.39
  • 52 Week High
  • APLS $71.90
  • IPAR $154.39
  • Technical
  • Relative Strength Index (RSI)
  • APLS 38.99
  • IPAR 45.94
  • Support Level
  • APLS $26.84
  • IPAR $132.21
  • Resistance Level
  • APLS $28.59
  • IPAR $141.15
  • Average True Range (ATR)
  • APLS 1.12
  • IPAR 3.58
  • MACD
  • APLS -0.03
  • IPAR -0.74
  • Stochastic Oscillator
  • APLS 18.09
  • IPAR 23.04

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Share on Social Networks: